| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |